these - Université de Franche-Comté

101 Gommers D, Eijking EP, So KL, van't Veen A, Lachmann B.
Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant
instillation improves the effectiveness of surfactant therapy in experimental acute
respiratory distress syndrome (ARDS).
Intensive Care Med. 1998 May;24(5):494-500.
102 Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley
MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR,
Gold AJ.
Bovine surfactant therapy for patients with acute respiratory distress syndrome.
Am J Respir Crit Care Med. 1997 Apr;155(4):1309-15.
103 Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte
MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W.
Effect of recombinant surfactant protein C-based surfactant on the acute respiratory
distress syndrome.
N Engl J Med. 2004 Aug; 26;351(9):884-92.
104 Haitsma JJ, Papadakos PJ, Lachmann B.
Surfactant therapy for acute lung injury/acute respiratory distress syndrome.
Curr Opin Crit Care. 2004 Feb;10(1):18-22.
105 Lewis JF, Veldhuizen R.
The role of exogenous surfactant in the treatment of acute lung injury.
Annu Rev Physiol. 2003;65:613-42. Epub 2002 May 01.
106 Hafner D, Germann PG, Hauschke D.
Comparison of rSP-C surfactant with natural and synthetic surfactants after late
treatment in a rat model of the acute respiratory distress syndrome.
Br J Pharmacol. 1998 Jul;124(6):1083-90.
151